Navigation Links
Study examines how breastfeeding impacts cost of care for very low birth weight infants
Date:12/16/2008

(CHICAGO) The National Institutes of Health (NIH) has awarded nearly $3 million to support Rush University Medical Center's study analyzing how human breast milk impacts the health outcomes and health care cost savings for very low birth weight infants babies less than 1500 grams.

The grant will enable researchers at Rush to conduct a five-year study involving the largest prospective cohort of 600 very low birth weight infants born to racially and economically diverse mothers. The study will have a representative number of African American and low income women enrolled in this study.

"Unlike other institutions with the same demographics, the mothers that give birth at Rush elect to provide breast milk because they are encouraged to think of their milk as 'medicine' for their babies," said Paula Meier, director of clinical research and lactation in the Rush neonatal intensive care unit (NICU) and principal investigator of the study.

More than 95 percent of very low birth weight infants in Rush's NICU receive their mothers' breast milk and will be enrolled into the study.

The trial will examine the relationship between the amount, the duration, and the timing of human milk feedings and improved health outcomes for very low birth weight babies hospitalized in the NICU.

Past research indicates that human milk protects very low birth weight infants from prematurity-specific complications that predispose these infants to short-and long-term health problems and increase cost of health care.

"However, no one has conclusively linked the amount and length of time these infants need to be fed human milk in order to lower their health risks and tie it back to cost of care," said Meier.

"For this patient population, human milk is much more important for its therapeutic and medicinal properties rather than nutrition," said Meier. "While these infants are in the NICU, we have a critical window to decrease morbidity rates and risks of severe complications."

The study will follow very low birth weight infants in the Rush NICU to see what effect higher doses of human breast milk and longer periods of exposure during critical periods of hospitalization have on length of stay, infant growth, as well as lowering total NICU costs.

Infants enrolled in the study will receive different amounts of human breast milk during their NICU stay. Data on the variables of dose and exposure period of human breast milk feeding will be collected throughout the infant's entire NICU stay. Researchers also will collect data on short-term costs of providing breast milk such as breast pump rental, total number of storage containers needed and access to lactation experts.

"The findings from this study will be easily translated into health policy that we hope will help shape protocol standards for NICUs and providing care for this vulnerable patient population," said Meier.


'/>"/>

Contact: Deborah Song
deb_song@rush.edu
312-942-0588
Rush University Medical Center
Source:Eurekalert

Related medicine news :

1. Abused women seek more infant health care, MU study finds
2. New Easter Seals-MassMutual Study: Autism Strains Family Finances, Threatens Long-Term Care and Security
3. Easter Seals Study Sheds New Light on Parents Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism
4. QLT announces interim results of radical study evaluating Visudyne combination therapy
5. Newly discovered esophagus stem cells grow into transplantable tissue, Penn study finds
6. Study to identify best rehabilitation therapies for patients with traumatic brain injuries
7. Double Blind Study Proves The Pink Patch Works for Weight Loss
8. First Patient from CyberKnife Center of Palm Beach Enrolled in Worldwide Landmark Study of Operable Lung Cancer Patients
9. Planned safety analysis of a breast cancer prevention study reveals encouraging news for Exemestane
10. Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
11. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: